Verastem Oncology
VSTM
#7530
Rank
โ‚ฌ0.29 B
Marketcap
6,52ย โ‚ฌ
Share price
-1.60%
Change (1 day)
-33.49%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -โ‚ฌ85.28 Million

According to Verastem Oncology 's latest financial reports the company's current earnings are โ‚ฌ10 Million. In 2023 the company made an earning of -โ‚ฌ80.3 Million a decrease over its 2022 earnings that were of -โ‚ฌ67.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ85.28 Million6.2%
2023 -โ‚ฌ80.3 Million18.36%
2022 -โ‚ฌ67.84 Million3.67%
2021 -โ‚ฌ65.44 Million5.43%
2020 -โ‚ฌ62.07 Million-54.74%
2019 -โ‚ฌ0.14 Billion105.99%
2018 -โ‚ฌ66.57 Million6.83%
2017 -โ‚ฌ62.32 Million86.06%
2016 -โ‚ฌ33.49 Million-37.03%
2015 -โ‚ฌ53.18 Million8.43%
2014 -โ‚ฌ49.05 Million29.52%
2013 -โ‚ฌ37.87 Million28.6%
2012 -โ‚ฌ29.45 Million133.9%
2011 -โ‚ฌ12.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ41.18 Million-52.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.38 B-7,529.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.75 B-979.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.83 B-4,563.02%๐Ÿ‡ฌ๐Ÿ‡ง UK